APA (7th ed.) Citation

Gina M. Coudriet, Meghan M. Delmastro-Greenwood, Dana M. Previte, Meghan L. Marré, Erin C. O'Connor, Elizabeth A. Novak, . . . Jon D. Piganelli. (2017). Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. MDPI AG.

Chicago Style (17th ed.) Citation

Gina M. Coudriet, et al. Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. MDPI AG, 2017.

MLA (9th ed.) Citation

Gina M. Coudriet, et al. Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. MDPI AG, 2017.